Crynodeb

OCID:

Cyhoeddwyd gan:

NHS Brighton and Hove Clinical Commissioning Group

ID Awudurdod:

AA72972

Dyddiad cyhoeddi:

28 Medi 2018

Dyddiad Cau:

-

Math o hysbysiad:

Dyfarnu Contract

Mae ganddo ddogfennau:

Nac Ydi

Wedi SPD:

Nac Ydi

Mae ganddo gynllun lleihau carbon:

AMH

Crynodeb

Aims

The CCG wishes to offer a clinically effective and safe, standardised anti-coagulation management service to patients receiving anti-coagulation therapy, within Brighton and Hove, offering choice and flexibility to the patient as to how and where their therapy is conducted.

The service is required to enable a cohort of eligible patients to test their own INR at home. Patients will be identified using eligibility criteria outlined in the service specification. The service will then train and assess the patients’ ability to use their own meter and read and record test their INR results. The service will manage and monitor individuals self-testing to ensure appropriate frequency of INR testing.

The service will support patient choice and refer back to primary care where a DOAC is considered as a more preferable and appropriate option at initiation (rather than warfarin) or switching to a DOAC would be clinically preferable when identified.

The service is also responsible for training of its own practitioners to the required standard to deliver the service provision of equipment and consumables, IM&T enabling read-only access for GPs. The service is responsible for ensuring consumable clinical and non-clinical equipment is stored appropriately.

The service is responsible for carrying out internal clinical audit. Should the CCG require any audit information, this will be shared with the CCG in a timely manner. The CCG will provide at least 6 weeks’ notice to the provider.